
|Videos|February 16, 2022
2022 ASCO GU Overview: Dr. Ibilibor on metastatic UC, RCC, and rare cancers
Author(s)Urology Times staff
Christine Ibilibor, MD, discusses 6 noteworthy abstracts from the 2022 Genitourinary Cancers Symposium.
Advertisement
Episodes in this series
In this video, Urology Times® Editorial Council member Christine Ibilbor, MD, discusses abstracts on metastatic urothelial carcinoma, renal cell carcinoma, and rare cancers that will be presented at the 2022 Genitourinary Cancers Symposium. Ibilibor is an assistant professor of urology at the University of Virginia in Charlottesville.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5




















